Lantern Pharma Inc.
NASDAQ:LTRN
Lantern Pharma Inc.
NASDAQ:LTRN
Price:
1.76
USD
8.64%
Market Closed
Market Cap:
$19.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lantern Pharma Inc.
NASDAQ:LTRN
|
US |
|
S
|
Shenzhen Pagoda Industrial Group Corp Ltd
HKEX:2411
|
CN |
|
Shree Digvijay Cement Co Ltd
NSE:SHREDIGCEM
|
IN |
|
Murchison Minerals Ltd
XTSX:MUR
|
CA |
|
Paranovus Entertainment Technology Ltd
NASDAQ:PAVS
|
CN |
|
Antisense Therapeutics Ltd
ASX:ANP
|
AU |
|
G
|
Guangdong Xinbao Electrical Appliances Holdings Co Ltd
SZSE:002705
|
CN |
|
I
|
Indo Asia Finance Ltd
BSE:530747
|
IN |
|
A
|
Armada Acquisition Corp II
NASDAQ:XRPN
|
KY |
|
EIH Ltd
NSE:EIHOTEL
|
IN |
|
A
|
Ashirwad Capital Ltd
BSE:512247
|
IN |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
U
|
Univar Solutions Inc
F:0UV
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LTRN.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LTRN
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
LTRN Competitors Multiples
Lantern Pharma Inc. Competitors
Lantern Pharma Inc. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lantern Pharma Inc.
NASDAQ:LTRN
|
19.4m USD | 0 | -1 | -0.4 | -0.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.7 | 37.5 | 40.8 | 41.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
